< 1 minute read
Nov. 26, 2021
Sivopixant: A P2X3 ligand-gated Ion Channel Antagonist
S-600918
purinergic receptor (ion channel) antagonist up to 300 mg PO QD, phase IIb, chronic cough from opt. of prior P2X3 antagonist Bioorganic and Medicinal Chemistry Letters Shionogi